James Larkin
James Larkin is a postdoctoral researcher at the Royal College of Surgeons in Ireland (RCSI), known for his examination of conflicts of interest within the pharmaceutical industry. He gained attention for obtaining a report from the Health Products Regulatory Authority (HPRA) that revealed significant non-compliance by Novo Nordisk regarding the advertising and marketing of their weight loss drugs, Ozempic and Wegovy.
Born on Jan 21, 1876 (149 years old)
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Ireland:
Another labour connection between Liverpool and Dublin is James Larkin, who was born in the city’s Toxteth area.
7
South Africa:
James Larkin leads the University of the Witwatersrand Rhisotope Project, which uses nuclear technology to combat rhino poaching.
9
China:
James Larkin is the chief scientist of the Rhino Isotope Project at the University of Cape Town.
8
Luxembourg:
Professor James Larkin is the scientific leader of the Rhisotope project.
9
Greece:
James Larkin is the chief scientific advisor of the Rhisotope Project.
9
United Kingdom:
James Larkin is a professor at Wits University and part of the Rhisotope Project.
9
United Kingdom:
James Larkin is the chief scientific officer at the Rhisotope Project.
9
Ireland:
The ‘movements for reform’ section featured an interesting question comparing the successes of Michael Davitt and James Larkin.
6
Ireland:
James Larkin is a senior postdoctoral fellow in the department of General Practice at RCSI.
6
Ireland:
James Larkin is a postdoctoral researcher in the Royal College of Surgeons in Ireland who examines conflicts of interest.
7